“EVO ICL is the next logical step in refractive innovation. While adoption of any new technology takes time, EVO ICL’s adoption rate has been steadily rising since launch – achieving market leadership ...
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, ...
Modern Vision Centers has released a new article titled “The Truth About EVO ICL and Glare: What Research Actually Shows,” addressing one of the most common questions patients have about implantable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results